Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of epidermis development.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of epidermis development"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
HOXB5 | homeobox B5 | 0.993 | Human | |
SRSF4 | serine/arginine-rich splicing factor 4 | 0.991 | Human | |
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.974 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.962 | ||
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.930 | Human | |
HOXA5 | homeobox A5 | 0.888 | Human | |
EED | embryonic ectoderm development | 0.883 | ||
JUP | junction plakoglobin | 0.846 | ||
SRSF6 | serine/arginine-rich splicing factor 6 | 0.800 | ||
CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.781 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.754 | ||
HOXA10 | homeobox A10 | 0.740 | ||
HOXB6 | homeobox B6 | 0.535 | Human | |
DSG2 | desmoglein 2 | 0.528 | ||
KRT5 | keratin 5 | 0.524 | ||
SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.485 | ||
HOXB7 | homeobox B7 | 0.464 | Human | |
HOXB3 | homeobox B3 | 0.431 | ||
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.415 | ||
HOXA7 | homeobox A7 | 0.374 | ||
HOXA11 | homeobox A11 | 0.294 | ||
HOXB9 | homeobox B9 | 0.271 | ||
HOXA4 | homeobox A4 | 0.264 | Human | |
BBS10 | Bardet-Biedl syndrome 10 | 0.163 | ||
HOXC10 | homeobox C10 | 0.126 | ||
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.116 | ||
TRA2B | transformer 2 beta homolog (Drosophila) | 0.113 | ||
RNPS1 | RNA binding protein S1, serine-rich domain | 0.110 | ||
PSEN1 | presenilin 1 | 0.109 | ||
CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.106 | ||
MSX1 | msh homeobox 1 | 0.099 | ||
DSP | desmoplakin | 0.097 | ||
FSTL1 | follistatin-like 1 | 0.079 | ||
HOXA2 | homeobox A2 | 0.077 | ||
HOXA6 | homeobox A6 | 0.076 | Human | |
SATB2 | SATB homeobox 2 | 0.062 | ||
PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.053 | ||
HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 0.046 | ||
CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.045 | ||
PKP3 | plakophilin 3 | 0.044 | ||
SRRM1 | serine/arginine repetitive matrix 1 | 0.042 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.042 | ||
RBBP4 | retinoblastoma binding protein 4 | 0.040 | ||
U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 0.039 | ||
TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.037 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.035 | ||
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.034 | ||
HOXA1 | homeobox A1 | 0.031 | ||
UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.028 | ||
RBM39 | RNA binding motif protein 39 | 0.028 | ||
MAT2A | methionine adenosyltransferase II, alpha | 0.028 | ||
HOXB4 | homeobox B4 | 0.027 | Human | |
FUS | fused in sarcoma | 0.026 | ||
SRRM2 | serine/arginine repetitive matrix 2 | 0.025 | ||
H3F3B | H3 histone, family 3B (H3.3B) | 0.025 | ||
HOXA3 | homeobox A3 | 0.025 | ||
SREK1 | splicing regulatory glutamine/lysine-rich protein 1 | 0.023 | ||
SRSF7 | serine/arginine-rich splicing factor 7 | 0.021 | ||
HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 0.021 | ||
KRT14 | keratin 14 | 0.019 | ||
KRT6C | keratin 6C | 0.018 | ||
NOTCH1 | notch 1 | 0.017 | ||
HOXB2 | homeobox B2 | 0.017 | ||
SRPK1 | SRSF protein kinase 1 | 0.016 | ||
CCND2 | cyclin D2 | 0.016 | ||
HOXB8 | homeobox B8 | 0.016 | Human | |
HOXC13 | homeobox C13 | 0.015 | ||
HOXC11 | homeobox C11 | 0.014 | ||
SMAD6 | SMAD family member 6 | 0.013 | ||
HOXC6 | homeobox C6 | 0.013 | Human | |
FXYD3 | FXYD domain containing ion transport regulator 3 | 0.012 | ||
HOXD10 | homeobox D10 | 0.012 | ||
ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.012 | ||
NOTCH3 | notch 3 | 0.012 | ||
CTNNBIP1 | catenin, beta interacting protein 1 | 0.011 | ||
TOE1 | target of EGR1, member 1 (nuclear) | 0.010 | ||
FRMD5 | FERM domain containing 5 | 0.010 |